Nahdi Medical Company
4164
Kedudukan dalam Saham
#4842
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Harga Saham
$23.53
Disegerakkan terakhir: 2026-10-19
Modal Pasaran
$3.06B
Perubahan (1 hari)
-0.95%
Perubahan (1 tahun)
-26.76%
Negara
SA
Perdagangan Nahdi Medical Company (4164)
Kategori
Healthcare
Pendapatan untuk Nahdi Medical Company (4164)
Pendapatan pada Jun 2026 TTM: $217.74M
Menurut laporan kewangan terkini Nahdi Medical Company, pendapatan semasa syarikat ialah $217.74M. Pada tahun 2023, syarikat memperoleh pendapatan sebanyak $251.81M, peningkatan berbanding pendapatan pada tahun 2022 yang berjumlah $249.53M. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Nahdi Medical Company dari 2017 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Ubah |
|---|---|---|
| 2026 (TTM) | $217.74M | -1.98% |
| 2024 | $222.14M | -11.78% |
| 2023 | $251.81M | 0.91% |
| 2022 | $249.53M | 9.27% |
| 2021 | $228.35M | -4.23% |
| 2020 | $238.42M | 16.36% |
| 2019 | $204.91M | 20.34% |
| 2018 | $170.27M | -15.09% |
| 2017 | $200.53M | 0.00% |
Pendapatan untuk syarikat atau pesaing serupa
| Syarikat | Pendapatan | Perbezaan Pendapatan | Negara |
|---|---|---|---|
| $1.35B | 519.94% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $1.21B | 453.44% |
HK
|
